Expanded response letter to "Hemodialysis dose and frequency should be considered in the subgroup analysis"

被引:1
作者
Lin, Li-Chun [1 ]
Wang, Chung-An [2 ]
Wu, Vin-Cent [1 ,3 ,4 ,5 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Primary aldosteronism Ctr Internal Med, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp Study Grp Acute Renal Failur, Taipei, Taiwan
[5] Taiwan Consortium Acute Kidney Injury & Renal Dis, Taipei, Taiwan
关键词
D O I
10.1186/s12933-024-02483-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 2 条
  • [1] TriNetX Data Dictionary, Stony Brook Medicine
  • [2] Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis
    Wang, Chung-An
    Lin, Li-Chun
    Chen, Jui-Yi
    Wang, Wei-Jie
    Wu, Vin-Cent
    [J]. CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)